Related Experiment Video
Updated: Jul 15, 2026

08:47
Oral Health Assessment by Lay Personnel for Older Adults
Published on: February 2, 2020
Quality of life in dementia
1Division of General Internal Medicine, University Health Network, Canada.
Summary
Measuring quality of life (QOL) in dementia is crucial but lacks consensus. This review examines current QOL assessment methods for dementia interventions, highlighting the need for standardized approaches in clinical trials.
Area of Science:
- Gerontology
- Neuroscience
- Clinical Psychology
Background:
- Quality of life (QOL) is increasingly recognized as a vital outcome measure for dementia interventions.
- Despite consensus on its importance, standardized methods for assessing QOL in dementia are lacking.
- Current approaches include patient self-report, caregiver proxy reports, and observational assessments.
Purpose of the Study:
- To review the current landscape of Quality of Life (QOL) assessment methodologies in dementia.
- To identify various approaches and instruments used for measuring QOL in individuals with dementia.
- To highlight the limited inclusion of QOL as an outcome in pharmacotherapy clinical trials for dementia.
Main Methods:
- Literature review of existing QOL assessment strategies in dementia research.
- Analysis of dementia-specific and generic QOL measures.
- Examination of QOL's role in clinical trials for dementia pharmacotherapy.
Main Results:
- Multiple methods for QOL assessment exist, including self-report, proxy-report, and observational methods.
- Both dementia-specific and generic QOL measures have been utilized.
- QOL is infrequently incorporated as an outcome measure in pharmacotherapy trials for dementia.
Conclusions:
- There is a significant need for agreement on standardized QOL assessment tools for dementia.
- Further integration of QOL measures into clinical trials is essential for comprehensive intervention evaluation.
- Standardized QOL assessment will improve the evaluation of dementia treatments and interventions.
Related Concept Videos
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Documentation in Long-Term and Home Healthcare Setting
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
